-
1
-
-
0033006836
-
Cancer statistics, 1999
-
Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8-31, 1.
-
(1999)
CA Cancer J Clin
, vol.49
, pp. 8-31
-
-
Landis, S.H.1
Murray, T.2
Bolden, S.3
-
2
-
-
0031044884
-
Increasing incidence of minimal residual cancer in radical prostatectomy specimens
-
DiGiuseppe JA, Sauvageot J, Epstein JI. Increasing incidence of minimal residual cancer in radical prostatectomy specimens. Am J Surg Pathol. 1997;21:174-178.
-
(1997)
Am J Surg Pathol
, vol.21
, pp. 174-178
-
-
DiGiuseppe, J.A.1
Sauvageot, J.2
Epstein, J.I.3
-
3
-
-
0028850857
-
Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy
-
Epstein JI. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol. 1995;26:223-229.
-
(1995)
Hum Pathol
, vol.26
, pp. 223-229
-
-
Epstein, J.I.1
-
4
-
-
0030585906
-
Assessment of prostate carcinoma in core needle biopsy: Definition of minimal criteria for the diagnosis of cancer in biopsy material
-
Algaba F, Epstein JI, Aldape HC, et al. Assessment of prostate carcinoma in core needle biopsy: definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer. 1996;78:376-381.
-
(1996)
Cancer
, vol.78
, pp. 376-381
-
-
Algaba, F.1
Epstein, J.I.2
Aldape, H.C.3
-
5
-
-
0034523813
-
Minimal adenocarcinoma in prostate needle biopsy tissue
-
Thorson P, Humphrey PA. Minimal adenocarcinoma in prostate needle biopsy tissue. Am J Clin Pathol. 2000;114:896-909.
-
(2000)
Am J Clin Pathol
, vol.114
, pp. 896-909
-
-
Thorson, P.1
Humphrey, P.A.2
-
6
-
-
0020082066
-
A simplified purification procedure for human prostate antigen
-
Wang MC, Valenzuela LA, Murphy GP, et al. A simplified purification procedure for human prostate antigen. Oncology. 1982;39:1-5.
-
(1982)
Oncology
, vol.39
, pp. 1-5
-
-
Wang, M.C.1
Valenzuela, L.A.2
Murphy, G.P.3
-
7
-
-
0028256194
-
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men
-
Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994;151:1283-1290.
-
(1994)
J Urol
, vol.151
, pp. 1283-1290
-
-
Catalona, W.J.1
Richie, J.P.2
Ahmann, F.R.3
-
8
-
-
0032855594
-
Prostate specific antigen: A decade of discovery: What we have learned and where we are going
-
Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery: what we have learned and where we are going. J Urol. 1999;162:293-306.
-
(1999)
J Urol
, vol.162
, pp. 293-306
-
-
Polascik, T.J.1
Oesterling, J.E.2
Partin, A.W.3
-
9
-
-
0027956731
-
Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia
-
Hasui Y, Marutsuka K, Asada Y, et al. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate. 1994;25:91-96.
-
(1994)
Prostate
, vol.25
, pp. 91-96
-
-
Hasui, Y.1
Marutsuka, K.2
Asada, Y.3
-
10
-
-
0029072827
-
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels
-
Nadler RB, Humphrey PA, Smith DS, et al. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 1995;154:407-413.
-
(1995)
J Urol
, vol.154
, pp. 407-413
-
-
Nadler, R.B.1
Humphrey, P.A.2
Smith, D.S.3
-
11
-
-
0027878069
-
Prostatic acid phosphatase in 1993: Its limited clinical utility
-
Lowe FC, Trauzzi SJ. Prostatic acid phosphatase in 1993: its limited clinical utility. Urol Clin North Am. 1993;20:589-595.
-
(1993)
Urol Clin North Am
, vol.20
, pp. 589-595
-
-
Lowe, F.C.1
Trauzzi, S.J.2
-
12
-
-
0023177172
-
Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate
-
Oesterling JE, Brendler CB, Epstein JI, et al. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol. 1987;138:92-98.
-
(1987)
J Urol
, vol.138
, pp. 92-98
-
-
Oesterling, J.E.1
Brendler, C.B.2
Epstein, J.I.3
-
13
-
-
0023547004
-
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
-
Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res. 1987;7:927-935.
-
(1987)
Anticancer Res
, vol.7
, pp. 927-935
-
-
Horoszewicz, J.S.1
Kawinski, E.2
Murphy, G.P.3
-
14
-
-
0027500319
-
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen
-
Israeli RS, Powell CT, Fair WR, et al. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res. 1993;53:227-230.
-
(1993)
Cancer Res
, vol.53
, pp. 227-230
-
-
Israeli, R.S.1
Powell, C.T.2
Fair, W.R.3
-
15
-
-
0024208759
-
Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate
-
Teni TR, Sheth AR, Kamath MR, et al. Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate. Cancer Lett. 1988;43:9-14.
-
(1988)
Cancer Lett
, vol.43
, pp. 9-14
-
-
Teni, T.R.1
Sheth, A.R.2
Kamath, M.R.3
-
16
-
-
0020081619
-
Proteins of human urine, II: Identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer
-
Edwards JJ, Anderson NG, Tollaksen SL, et al. Proteins of human urine, II: identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer. Clin Chem. 1982;28:160-163.
-
(1982)
Clin Chem
, vol.28
, pp. 160-163
-
-
Edwards, J.J.1
Anderson, N.G.2
Tollaksen, S.L.3
-
17
-
-
0024533628
-
Molecular characterization of the epitope in prostate and breast tumor-associated PR92 antigen
-
Kim YD, Robinson DY, Manderino GL, et al. Molecular characterization of the epitope in prostate and breast tumor-associated PR92 antigen. Cancer Res. 1989;49:2379-2382.
-
(1989)
Cancer Res
, vol.49
, pp. 2379-2382
-
-
Kim, Y.D.1
Robinson, D.Y.2
Manderino, G.L.3
-
18
-
-
0025890304
-
A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27
-
Wright GL Jr, Beckett ML, Lipford GB, et al. A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27. Int J Cancer. 1991;47:717-725.
-
(1991)
Int J Cancer
, vol.47
, pp. 717-725
-
-
Wright Jr., G.L.1
Beckett, M.L.2
Lipford, G.B.3
-
19
-
-
0025728912
-
Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas
-
Beckett ML, Lipford GB, Haley CL, et al. Monoclonal antibody PD41 recognizes an antigen restricted to prostate adenocarcinomas. Cancer Res. 1991;51:1326-1333.
-
(1991)
Cancer Res
, vol.51
, pp. 1326-1333
-
-
Beckett, M.L.1
Lipford, G.B.2
Haley, C.L.3
-
20
-
-
0028718134
-
12-Lipoxygenase, 12(S)-HETE, and cancer metastasis
-
Tang DG, Honn KV. 12-Lipoxygenase, 12(S)-HETE, and cancer metastasis. Ann N Y Acad Sci. 1994;744:199-215.
-
(1994)
Ann N Y Acad Sci
, vol.744
, pp. 199-215
-
-
Tang, D.G.1
Honn, K.V.2
-
21
-
-
0027139144
-
p53 expression and clinical outcome in prostate cancer
-
Thomas DJ, Robinson M, King P, et al. p53 expression and clinical outcome in prostate cancer. Br J Urol. 1993;72:778-781.
-
(1993)
Br J Urol
, vol.72
, pp. 778-781
-
-
Thomas, D.J.1
Robinson, M.2
King, P.3
-
22
-
-
0001746766
-
Role of p27 in prostate carcinogenesis
-
Macri E, Loda M. Role of p27 in prostate carcinogenesis. Cancer Metastasis Rev. 1998;17:337-344.
-
(1998)
Cancer Metastasis Rev
, vol.17
, pp. 337-344
-
-
Macri, E.1
Loda, M.2
-
23
-
-
0035939903
-
Delineation of prognostic biomarkers in prostate cancer
-
Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412:822-826.
-
(2001)
Nature
, vol.412
, pp. 822-826
-
-
Dhanasekaran, S.M.1
Barrette, T.R.2
Ghosh, D.3
-
24
-
-
0037846472
-
Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer
-
Rhodes DR, Sanda MG, Otte AP, et al. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst. 2003;95:661-668.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 661-668
-
-
Rhodes, D.R.1
Sanda, M.G.2
Otte, A.P.3
-
25
-
-
18644382388
-
The polycomb group protein EZH2 is involved in progression of prostate cancer
-
Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419:624-629.
-
(2002)
Nature
, vol.419
, pp. 624-629
-
-
Varambally, S.1
Dhanasekaran, S.M.2
Zhou, M.3
-
26
-
-
0021927118
-
Keratin immunoreactivity in the benign and neoplastic human prostate
-
Brawer MK, Peehl DM, Stamey TA, et al. Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res. 1985;45:3663-3667.
-
(1985)
Cancer Res
, vol.45
, pp. 3663-3667
-
-
Brawer, M.K.1
Peehl, D.M.2
Stamey, T.A.3
-
27
-
-
0021332859
-
Monoclonal antibodies to human intermediate filament proteins, II: Distribution of filament proteins in normal human tissues
-
Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins, II: distribution of filament proteins in normal human tissues. Am J Pathol. 1984;114:309-321.
-
(1984)
Am J Pathol
, vol.114
, pp. 309-321
-
-
Gown, A.M.1
Vogel, A.M.2
-
28
-
-
0030911101
-
The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy
-
Henneberry JM, Kahane H, Humphrey PA, et al. The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy. Am J Surg Pathol. 1997;21:725-728.
-
(1997)
Am J Surg Pathol
, vol.21
, pp. 725-728
-
-
Henneberry, J.M.1
Kahane, H.2
Humphrey, P.A.3
-
29
-
-
0028937357
-
The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer: A review of 228 cases
-
Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer: a review of 228 cases. Am J Surg Pathol. 1995;19:251-260.
-
(1995)
Am J Surg Pathol
, vol.19
, pp. 251-260
-
-
Wojno, K.J.1
Epstein, J.I.2
-
30
-
-
0033637118
-
p63 is a prostate basal cell marker and is required for prostate development
-
Signoretti S, Waltregny D, Dilks J, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000;157:1769-1775.
-
(2000)
Am J Pathol
, vol.157
, pp. 1769-1775
-
-
Signoretti, S.1
Waltregny, D.2
Dilks, J.3
-
31
-
-
0024566709
-
Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma
-
Hedrick L, Epstein JI. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol. 1989;13:389-396.
-
(1989)
Am J Surg Pathol
, vol.13
, pp. 389-396
-
-
Hedrick, L.1
Epstein, J.I.2
-
32
-
-
0034654176
-
Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
-
Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000;60:1677-1682.
-
(2000)
Cancer Res
, vol.60
, pp. 1677-1682
-
-
Xu, J.1
Stolk, J.A.2
Zhang, X.3
-
33
-
-
0033747547
-
Subcellular localization and physiological role of alpha-methylacyl-CoA racemase
-
Ferdinandusse S, Denis S, IJist L, et al. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res. 2000;41:1890-1896.
-
(2000)
J Lipid Res
, vol.41
, pp. 1890-1896
-
-
Ferdinandusse, S.1
Denis, S.2
Ijist, L.3
-
34
-
-
0034765524
-
P504S: A new molecular marker for the detection of prostate carcinoma
-
Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.
-
(2001)
Am J Surg Pathol
, vol.25
, pp. 1397-1404
-
-
Jiang, Z.1
Woda, B.A.2
Rock, K.L.3
-
35
-
-
0037012476
-
α-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
-
Rubin MA, Zhou M, Dhanasekaran SM, et al. α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662-1670.
-
(2002)
JAMA
, vol.287
, pp. 1662-1670
-
-
Rubin, M.A.1
Zhou, M.2
Dhanasekaran, S.M.3
-
36
-
-
17344393447
-
Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer
-
Luo J, Zha S, Gage WR, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res. 2002;62:2220-2226.
-
(2002)
Cancer Res
, vol.62
, pp. 2220-2226
-
-
Luo, J.1
Zha, S.2
Gage, W.R.3
-
37
-
-
0036891945
-
P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies
-
Beach R, Gown AM, De Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588-1596.
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 1588-1596
-
-
Beach, R.1
Gown, A.M.2
De Peralta-Venturina, M.N.3
-
38
-
-
0037343327
-
Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone
-
Leav I, McNeal JE, Ho SM, et al. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Hum Pathol. 2003;34:228-233.
-
(2003)
Hum Pathol
, vol.34
, pp. 228-233
-
-
Leav, I.1
McNeal, J.E.2
Ho, S.M.3
-
39
-
-
0034939233
-
The pathological interpretation and significance of prostate needle biopsy findings: Implications and current controversies
-
Epstein JI, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol. 2001;166:402-410.
-
(2001)
J Urol
, vol.166
, pp. 402-410
-
-
Epstein, J.I.1
Potter, S.R.2
-
40
-
-
84942475860
-
Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
-
Epstein JI, Walsh PC, Carmichael M, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271:368-374.
-
(1994)
JAMA
, vol.271
, pp. 368-374
-
-
Epstein, J.I.1
Walsh, P.C.2
Carmichael, M.3
-
41
-
-
0031317538
-
Benign mimics of prostatic adeno-carcinoma on needle biopsy
-
Gaudin PB, Reuter VE. Benign mimics of prostatic adeno-carcinoma on needle biopsy. Anat Pathol. 1997;2:111-134.
-
(1997)
Anat Pathol
, vol.2
, pp. 111-134
-
-
Gaudin, P.B.1
Reuter, V.E.2
-
42
-
-
0028947489
-
The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis
-
Cupp MR, Bostwick DG, Myers RP, et al. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol. 1995;153:1543-1548.
-
(1995)
J Urol
, vol.153
, pp. 1543-1548
-
-
Cupp, M.R.1
Bostwick, D.G.2
Myers, R.P.3
-
43
-
-
0028910389
-
Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues
-
Humphrey P, Baty J, Keetch D. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues. Cancer. 1995;75:1842-1849.
-
(1995)
Cancer
, vol.75
, pp. 1842-1849
-
-
Humphrey, P.1
Baty, J.2
Keetch, D.3
-
44
-
-
0036724798
-
P504S/alpha-methylacyl-CoA racemase: A useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy
-
Jiang Z, Wu CL, Woda BA, et al. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169-1174.
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 1169-1174
-
-
Jiang, Z.1
Wu, C.L.2
Woda, B.A.3
-
45
-
-
0042845930
-
Alpha-methylacyl-CoA racemase: A variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy
-
Magi-Galluzzi C, Luo J, Isaacs WB, et al. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol. 2003;27:1128-1133.
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 1128-1133
-
-
Magi-Galluzzi, C.1
Luo, J.2
Isaacs, W.B.3
-
46
-
-
0036300932
-
Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate
-
Yang XJ, Wu CL, Woda BA, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26:921-925.
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 921-925
-
-
Yang, X.J.1
Wu, C.L.2
Woda, B.A.3
-
47
-
-
0028853626
-
The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies
-
Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol. 1995;154:1791-1794.
-
(1995)
J Urol
, vol.154
, pp. 1791-1794
-
-
Bostwick, D.G.1
Qian, J.2
Frankel, K.3
-
48
-
-
0030662243
-
The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: Incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice
-
Cheville JC, Reznicek MJ, Bostwick DG. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108:633-640.
-
(1997)
Am J Clin Pathol
, vol.108
, pp. 633-640
-
-
Cheville, J.C.1
Reznicek, M.J.2
Bostwick, D.G.3
-
49
-
-
0032943822
-
Evaluation of prostate needle biopsies in a population-based screening study: The impact of borderline lesions
-
Hoedemaeker RF, Kranse R, Rietbergen JB, et al. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions. Cancer. 1999;85:145-152.
-
(1999)
Cancer
, vol.85
, pp. 145-152
-
-
Hoedemaeker, R.F.1
Kranse, R.2
Rietbergen, J.B.3
-
50
-
-
0032006961
-
Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States
-
Orozco R, O'Dowd G, Kunnel B, et al. Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology. 1998;51:186-195.
-
(1998)
Urology
, vol.51
, pp. 186-195
-
-
Orozco, R.1
O'Dowd, G.2
Kunnel, B.3
-
51
-
-
0032415442
-
Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies
-
Renshaw AA, Santis WF, Richie JP. Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol. 1998;159:2018-2022.
-
(1998)
J Urol
, vol.159
, pp. 2018-2022
-
-
Renshaw, A.A.1
Santis, W.F.2
Richie, J.P.3
-
52
-
-
0031922685
-
Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens
-
Reyes AO, Humphrey PA. Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens. Am J Clin Pathol. 1998;109:416-422.
-
(1998)
Am J Clin Pathol
, vol.109
, pp. 416-422
-
-
Reyes, A.O.1
Humphrey, P.A.2
-
53
-
-
0031745553
-
Diagnosis of "suspicious for malignancy" in prostate biopsies: Predictive value for cancer
-
Iczkowski KA, Bassler TJ, Schwob VS, et al. Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer. Urology. 1998;51:749-758.
-
(1998)
Urology
, vol.51
, pp. 749-758
-
-
Iczkowski, K.A.1
Bassler, T.J.2
Schwob, V.S.3
-
54
-
-
0030696286
-
Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: Clinical significance in 33 cases
-
Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol. 1997;21:1489-1495.
-
(1997)
Am J Surg Pathol
, vol.21
, pp. 1489-1495
-
-
Iczkowski, K.A.1
MacLennan, G.T.2
Bostwick, D.G.3
-
55
-
-
0347761214
-
P504S immunostaining boosts diagnostic resolution of " suspicious" foci in prostatic needle biopsy specimens
-
Jiang Z, Iczkowski KA, Woda BA, et al. P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens. Am J Clin Pathol. 2004;121:99-107.
-
(2004)
Am J Clin Pathol
, vol.121
, pp. 99-107
-
-
Jiang, Z.1
Iczkowski, K.A.2
Woda, B.A.3
-
56
-
-
0037838912
-
Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer
-
Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol. 2003;27:772-778.
-
(2003)
Am J Surg Pathol
, vol.27
, pp. 772-778
-
-
Zhou, M.1
Jiang, Z.2
Epstein, J.I.3
-
57
-
-
0348181906
-
Utility of immunohistochemistry for alpha-methylacyl CoA racemase (AMACR) in distinguishing atrophic prostate cancer from benign atrophy [abstract]
-
Farinola MA, Epstein JI. Utility of immunohistochemistry for alpha-methylacyl CoA racemase (AMACR) in distinguishing atrophic prostate cancer from benign atrophy [abstract]. Mod Pathol. 2003;16:149A.
-
(2003)
Mod Pathol
, vol.16
-
-
Farinola, M.A.1
Epstein, J.I.2
-
59
-
-
0028899807
-
Histologic effects of radiation therapy and total androgen blockage on prostate cancer
-
Grignon D, Sakr W. Histologic effects of radiation therapy and total androgen blockage on prostate cancer. Cancer. 1995;75:1837-1841.
-
(1995)
Cancer
, vol.75
, pp. 1837-1841
-
-
Grignon, D.1
Sakr, W.2
-
60
-
-
0032841660
-
Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues
-
Gaudin PB, Zelefsky MJ, Leibel SA, et al. Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol. 1999;23:1021-1031.
-
(1999)
Am J Surg Pathol
, vol.23
, pp. 1021-1031
-
-
Gaudin, P.B.1
Zelefsky, M.J.2
Leibel, S.A.3
-
61
-
-
0042123588
-
Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma
-
Yang XJ, Laven B, Tretiakova M, et al. Detection of alpha-methylacyl- coenzyme A racemase in postradiation prostatic adenocarcinoma. Urology. 2003;62:282-286.
-
(2003)
Urology
, vol.62
, pp. 282-286
-
-
Yang, X.J.1
Laven, B.2
Tretiakova, M.3
-
62
-
-
0347778669
-
Use of a novel immunohistochemical (IHC) panel (P504S, p63 and 34betaE12) in the diagnosis of post-radiation therapy (PRT) prostate cancer (PCa) [abstract]
-
Amin M, Beach R, Gown AM, et al. Use of a novel immunohistochemical (IHC) panel (P504S, p63 and 34betaE12) in the diagnosis of post-radiation therapy (PRT) prostate cancer (PCa) [abstract]. Mod Pathol. 2003;16:139A.
-
(2003)
Mod Pathol
, vol.16
-
-
Amin, M.1
Beach, R.2
Gown, A.M.3
-
63
-
-
0036731874
-
Alpha-methylacyl-CoA racemase: Expression levels of this novel cancer biomarker depend on tumor differentiation
-
Kuefer R, Varambally S, Zhou M, et al. Alpha-methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol. 2002;161:841-848.
-
(2002)
Am J Pathol
, vol.161
, pp. 841-848
-
-
Kuefer, R.1
Varambally, S.2
Zhou, M.3
-
64
-
-
0242610829
-
Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer
-
Zha S, Ferdinandusse S, Denis S, et al. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res. 2003;63:7365-7376.
-
(2003)
Cancer Res
, vol.63
, pp. 7365-7376
-
-
Zha, S.1
Ferdinandusse, S.2
Denis, S.3
-
65
-
-
0023746567
-
Premalignant lesions of the prostate
-
Bostwick DG. Premalignant lesions of the prostate. Semin Diagn Pathol. 1988;5:240-253.
-
(1988)
Semin Diagn Pathol
, vol.5
, pp. 240-253
-
-
Bostwick, D.G.1
-
66
-
-
0030018285
-
Prospective origins of prostate carcinoma: Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia
-
Bostwick DO. Prospective origins of prostate carcinoma: prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer. 1996;78:330-336.
-
(1996)
Cancer
, vol.78
, pp. 330-336
-
-
Bostwick, D.O.1
-
67
-
-
0034353132
-
Prostatic intraepithelial neoplasia: The preinvasive stage of prostate cancer: Overview of the prostate committee report
-
Bostwick DG, Norlen BJ, Denis L. Prostatic intraepithelial neoplasia: the preinvasive stage of prostate cancer: overview of the prostate committee report. Scand J Urol Nephrol Suppl. 2000;205:1-2.
-
(2000)
Scand J Urol Nephrol Suppl
, vol.205
, pp. 1-2
-
-
Bostwick, D.G.1
Norlen, B.J.2
Denis, L.3
-
68
-
-
0029096340
-
The significance of prostatic intra-epithelial neoplasia
-
Aboseif S, Shinohara K, Weidner N, et al. The significance of prostatic intra-epithelial neoplasia. Br J Urol. 1995;76:355-359.
-
(1995)
Br J Urol
, vol.76
, pp. 355-359
-
-
Aboseif, S.1
Shinohara, K.2
Weidner, N.3
-
69
-
-
0029045030
-
Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate
-
Keetch DW, Humphrey P, Stahl D, et al. Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol. 1995;154:347-351.
-
(1995)
J Urol
, vol.154
, pp. 347-351
-
-
Keetch, D.W.1
Humphrey, P.2
Stahl, D.3
-
70
-
-
0030098539
-
High-grade intraepithelial prostatic neoplasms: Diagnosis and association with prostate cancer [in French]
-
Raviv G, Janssen T, Zlotta AR, et al. High-grade intraepithelial prostatic neoplasms: diagnosis and association with prostate cancer [in French]. Acta Urol Belg. 1996;64:11-15.
-
(1996)
Acta Urol Belg
, vol.64
, pp. 11-15
-
-
Raviv, G.1
Janssen, T.2
Zlotta, A.R.3
-
71
-
-
0029164685
-
Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: Predictive accuracy in needle biopsies
-
Davidson D, Bostwick DG, Qian J, et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol. 1995;154:1295-1299.
-
(1995)
J Urol
, vol.154
, pp. 1295-1299
-
-
Davidson, D.1
Bostwick, D.G.2
Qian, J.3
-
72
-
-
0034017586
-
Analysis of repeated biopsy results within 1 year after a noncancer diagnosis
-
O'Dowd GJ, Miller MC, Orozco R, et al. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology. 2000;55:553-559.
-
(2000)
Urology
, vol.55
, pp. 553-559
-
-
O'Dowd, G.J.1
Miller, M.C.2
Orozco, R.3
-
73
-
-
0005250172
-
Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy
-
Shepherd D, Keetch DW, Humphrey PA, et al. Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol. 1996;156:460-463.
-
(1996)
J Urol
, vol.156
, pp. 460-463
-
-
Shepherd, D.1
Keetch, D.W.2
Humphrey, P.A.3
-
74
-
-
0027311244
-
Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy
-
Weinstein MH, Epstein JI. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol. 1993;24:624-629.
-
(1993)
Hum Pathol
, vol.24
, pp. 624-629
-
-
Weinstein, M.H.1
Epstein, J.I.2
-
75
-
-
0034928751
-
Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: Data on men with more than one follow-up biopsy
-
Kronz JD, Allan CH, Shaikh AA, et al. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol. 2001;25:1079-1085.
-
(2001)
Am J Surg Pathol
, vol.25
, pp. 1079-1085
-
-
Kronz, J.D.1
Allan, C.H.2
Shaikh, A.A.3
-
76
-
-
0020039694
-
Adenosis of the prostate: A dysplastic lesion that can be confused with prostate adenocarcinoma
-
Brawn PN. Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer. 1982;49:826-833.
-
(1982)
Cancer
, vol.49
, pp. 826-833
-
-
Brawn, P.N.1
-
77
-
-
0027220464
-
Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma
-
Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993;24:819-832.
-
(1993)
Hum Pathol
, vol.24
, pp. 819-832
-
-
Bostwick, D.G.1
Srigley, J.2
Grignon, D.3
-
78
-
-
0028018518
-
Adenosis of the prostate: Histologic features in transurethral resection specimens
-
Gaudin PB, Epstein JI. Adenosis of the prostate: histologic features in transurethral resection specimens. Am J Surg Pathol. 1994;18:863-870.
-
(1994)
Am J Surg Pathol
, vol.18
, pp. 863-870
-
-
Gaudin, P.B.1
Epstein, J.I.2
-
79
-
-
0028867479
-
The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: Relationship with carcinoma in radical prostatectomy specimens
-
Qian J, Bostwick DG. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens. Pathol Res Pract. 1995;191:860-867.
-
(1995)
Pathol Res Pract
, vol.191
, pp. 860-867
-
-
Qian, J.1
Bostwick, D.G.2
-
80
-
-
0021902741
-
Microscopic differential diagnosis of small acinar adenocarcinoma of prostate
-
Kovi J. Microscopic differential diagnosis of small acinar adenocarcinoma of prostate. Pathol Annu. 1985;20:157-196.
-
(1985)
Pathol Annu
, vol.20
, pp. 157-196
-
-
Kovi, J.1
-
81
-
-
0242388384
-
P504S antibody expression in putative precursor lesion of prostate carcinoma (PCa)-high grade prostatic intraepithelial neoplasia (HGPIN) and atypical adenomatous hyperplasia (AAH)
-
Gupta N, De Peralta-Venturina MN, Gown AM, et al. P504S antibody expression in putative precursor lesion of prostate carcinoma (PCa)-high grade prostatic intraepithelial neoplasia (HGPIN) and atypical adenomatous hyperplasia (AAH) [abstract]. Mod Pathol. 2003;16:152.
-
(2003)
Mod Pathol
, vol.16
, pp. 152
-
-
Gupta, N.1
De Peralta-Venturina, M.N.2
Gown, A.M.3
-
82
-
-
0038281356
-
Florid basal cell hyperplasia of the prostate: A histological, ultrastructural, and immunohistochemical analysis
-
Yang XJ, Tretiakova MS, Sengupta E, et al. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis. Hum Pathol. 2003;34:462-470.
-
(2003)
Hum Pathol
, vol.34
, pp. 462-470
-
-
Yang, X.J.1
Tretiakova, M.S.2
Sengupta, E.3
-
83
-
-
0347148551
-
Comparison of monoclonal antibody (P504S) and polyclonal antibody to α-methylacyl-CoA racemase in benign, atypical and malignant prostate tissues
-
Kunju LP, Rubin MA, Shen R, et al. Comparison of monoclonal antibody (P504S) and polyclonal antibody to α-methylacyl-CoA racemase in benign, atypical and malignant prostate tissues [abstract]. Mod Pathol. 2003;16:158A.
-
(2003)
Mod Pathol
, vol.16
-
-
Kunju, L.P.1
Rubin, M.A.2
Shen, R.3
-
84
-
-
0037194705
-
Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients
-
Mazal PR, Schaufler R, Altenhuber-Muller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med. 2002;347:653-659.
-
(2002)
N Engl J Med
, vol.347
, pp. 653-659
-
-
Mazal, P.R.1
Schaufler, R.2
Altenhuber-Muller, R.3
-
85
-
-
0041886959
-
Expression of alpha-methylacyl-CoA racemase (P504S) in various malignant neoplasms and normal tissues: A study of 761 cases
-
Jiang Z, Fanger GR, Woda BA, et al. Expression of alpha-methylacyl-CoA racemase (P504S) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol. 2003;34:792-796.
-
(2003)
Hum Pathol
, vol.34
, pp. 792-796
-
-
Jiang, Z.1
Fanger, G.R.2
Woda, B.A.3
-
86
-
-
0036306325
-
Alpha-methylacyl-CoA racemase: A novel tumor marker overexpressed in several human cancers and their precursor lesions
-
Zhou M, Chinnaiyan AM, Kleer CG, et al. Alpha-methylacyl-CoA racemase: a novel tumor marker overexpressed in several human cancers and their precursor lesions. Am J Surg Pathol. 2002;26:926-931.
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 926-931
-
-
Zhou, M.1
Chinnaiyan, A.M.2
Kleer, C.G.3
-
87
-
-
10744220888
-
A dietary enzyme: Alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma
-
Jiang Z, Fanger GR, Banner BF, et al. A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev. 2003;27:422-426.
-
(2003)
Cancer Detect Prev
, vol.27
, pp. 422-426
-
-
Jiang, Z.1
Fanger, G.R.2
Banner, B.F.3
-
88
-
-
0028982895
-
Purification and characterization of an alpha-methylacyl-CoA racemase from human liver
-
Schmitz W, Albers C, Fingerhut R, et al. Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. Eur J Biochem. 1995;231:815-822.
-
(1995)
Eur J Biochem
, vol.231
, pp. 815-822
-
-
Schmitz, W.1
Albers, C.2
Fingerhut, R.3
-
89
-
-
0442307867
-
Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer
-
Mubiru JN, Shen-Ong GL, Valente AJ, et al. Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer. Gene. 2004;327:89-98.
-
(2004)
Gene
, vol.327
, pp. 89-98
-
-
Mubiru, J.N.1
Shen-Ong, G.L.2
Valente, A.J.3
-
90
-
-
0037731330
-
Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology
-
Shen-Ong GL, Feng Y, Troyer DA. Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology. Cancer Res. 2003;63:3296-3301.
-
(2003)
Cancer Res
, vol.63
, pp. 3296-3301
-
-
Shen-Ong, G.L.1
Feng, Y.2
Troyer, D.A.3
-
91
-
-
0027423103
-
A prospective study of dietary fat and risk of prostate cancer
-
Giovannucci E, Rimm EB, Colditz GA, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst. 1993;85:1571-1579.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1571-1579
-
-
Giovannucci, E.1
Rimm, E.B.2
Colditz, G.A.3
-
92
-
-
0028576901
-
Dietary factors and risk of colon cancer
-
Giovannucci E, Willett WC. Dietary factors and risk of colon cancer. Ann Med. 1994;26:443-452.
-
(1994)
Ann Med
, vol.26
, pp. 443-452
-
-
Giovannucci, E.1
Willett, W.C.2
-
93
-
-
0042527219
-
Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro
-
Mobley JA, Leav I, Zielie P, et al. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol Biomarkers Prev. 2003;12:775-783.
-
(2003)
Cancer Epidemiol Biomarkers Prev
, vol.12
, pp. 775-783
-
-
Mobley, J.A.1
Leav, I.2
Zielie, P.3
-
94
-
-
0034815130
-
Human metabolism of phytanic acid and pristanic acid
-
Verhoeven NM, Jakobs C. Human metabolism of phytanic acid and pristanic acid. Prog Lipid Res. 2001;40:453-466.
-
(2001)
Prog Lipid Res
, vol.40
, pp. 453-466
-
-
Verhoeven, N.M.1
Jakobs, C.2
-
95
-
-
0037112526
-
Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk
-
Zheng SL, Chang BL, Faith DA, et al. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res. 2002;62:6485-6488.
-
(2002)
Cancer Res
, vol.62
, pp. 6485-6488
-
-
Zheng, S.L.1
Chang, B.L.2
Faith, D.A.3
-
96
-
-
0000021479
-
Incidence of occult adenocarcinoma of the prostate after 50 years of age
-
Baron E, Angrist A. Incidence of occult adenocarcinoma of the prostate after 50 years of age. Arch Pathol. 1941;32:787-793.
-
(1941)
Arch Pathol
, vol.32
, pp. 787-793
-
-
Baron, E.1
Angrist, A.2
|